S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Laser breakthrough could send stock soaring 2,467% (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Laser breakthrough could send stock soaring 2,467% (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Laser breakthrough could send stock soaring 2,467% (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Laser breakthrough could send stock soaring 2,467% (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Laser breakthrough could send stock soaring 2,467% (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
NYSE:HQL

Tekla Life Sciences Investors (HQL) Stock Forecast, Price & News

$12.38
-0.05 (-0.40%)
(As of 09/25/2023 ET)
Compare
Today's Range
$12.25
$12.44
50-Day Range
$12.38
$13.71
52-Week Range
$12.25
$15.30
Volume
100,113 shs
Average Volume
83,357 shs
Market Capitalization
$324.48 million
P/E Ratio
N/A
Dividend Yield
10.34%
Price Target
N/A

HQL stock logo

About Tekla Life Sciences Investors (NYSE:HQL) Stock

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

HQL Price History

HQL Stock News Headlines

Something is Coming for America's Top Stock
This stock has already doubled this year - but it could hurt your portfolio if you hold it much longer. Learn why here.
Tekla Life Sciences declares $0.32 dividend
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
HQL Tekla Life Sciences Investors
Tekla Life Sciences: Dividend Insights
Tekla Life Sciences Investors (NYSE: HQL)
HQL: A Biotechnology Equity CEF With No Leverage
Tekla Life Sciences cuts dividend by 10% to $0.35
5 Dividend Funds Yielding Up To 27.2%
Tekla Life Sciences Investors: 8% Yield, 7% Discount
Tekla Life Sciences Investors Declares Cash Distribution
Tekla Life Sciences Investors Declares Distribution
HQH: Deep Discount Leads To High Yield
HQL TeklaLife Sciences Investors Common Stock
See More Headlines
Receive HQL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter.

HQL Company Calendar

Ex-Dividend for 6/30 Dividend
5/24/2023
Dividend Payable
6/30/2023
Ex-Dividend for 9/29 Dividend
8/24/2023
Today
9/25/2023
Dividend Payable
9/29/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Investment offices, not elsewhere classified
Sub-Industry
N/A
Sector
Finance
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
23,575,000
Market Cap
$324.48 million
Optionable
Not Optionable
Beta
0.81
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Daniel R. Omstead M.S (Age 70)
    Ph.D., Principal Exec. Officer, Pres and Trustee













HQL Stock - Frequently Asked Questions

How have HQL shares performed in 2023?

Tekla Life Sciences Investors' stock was trading at $14.21 at the beginning of the year. Since then, HQL stock has decreased by 12.9% and is now trading at $12.38.
View the best growth stocks for 2023 here
.

Are investors shorting Tekla Life Sciences Investors?

Tekla Life Sciences Investors saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 25,700 shares, an increase of 71.3% from the August 15th total of 15,000 shares. Based on an average trading volume of 92,600 shares, the days-to-cover ratio is presently 0.3 days.
View Tekla Life Sciences Investors' Short Interest
.

How often does Tekla Life Sciences Investors pay dividends? What is the dividend yield for Tekla Life Sciences Investors?

Tekla Life Sciences Investors declared a quarterly dividend on Tuesday, August 15th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.32 per share on Friday, September 29th. This represents a $1.28 annualized dividend and a dividend yield of 10.34%. The ex-dividend date of this dividend is Thursday, August 24th.
Read our dividend analysis for HQL
.

Is Tekla Life Sciences Investors a good dividend stock?

Tekla Life Sciences Investors (NYSE:HQL) pays an annual dividend of $1.28 per share and currently has a dividend yield of 10.30%. HQL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for HQL.

What other stocks do shareholders of Tekla Life Sciences Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Life Sciences Investors investors own include NVIDIA (NVDA), Energy Transfer (ET), QUALCOMM (QCOM), AT&T (T), Enbridge (ENB), International Business Machines (IBM), Kinder Morgan (KMI), Main Street Capital (MAIN), Pfizer (PFE) and Weyerhaeuser (WY).

What is Tekla Life Sciences Investors' stock symbol?

Tekla Life Sciences Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQL."

Who are Tekla Life Sciences Investors' major shareholders?

Tekla Life Sciences Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.18%), Allspring Global Investments Holdings LLC (1.18%), Cornerstone Advisors LLC (0.98%), Wolverine Asset Management LLC (0.90%), Flagship Harbor Advisors LLC (0.92%) and Raymond James & Associates (0.63%). Insiders that own company stock include Daniel R Omstead, Daniel R Omstead and Kathleen Goetz.
View institutional ownership trends
.

How do I buy shares of Tekla Life Sciences Investors?

Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Life Sciences Investors' stock price today?

One share of HQL stock can currently be purchased for approximately $12.38.

How much money does Tekla Life Sciences Investors make?

Tekla Life Sciences Investors (NYSE:HQL) has a market capitalization of $324.48 million.

How can I contact Tekla Life Sciences Investors?

Tekla Life Sciences Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The official website for the company is www.teklacap.com. The company can be reached via phone at (617) 772-8500, via email at info@teklacap.com, or via fax at 617-772-8577.

This page (NYSE:HQL) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -